Actinium Pharmaceuticals, Inc. (ATNM)

NYSEAMERICAN: ATNM · Real-Time Price · USD

1.480

+0.050 (3.50%)

At close: May 9, 2025, 4:00 PM

1.480

0.00 (0.00%)

After-hours: May 9, 2025, 8:00 PM EDT

Actinium Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-38.24	-48.82	-33.02	-24.77	-22.22	Upgrade
Depreciation & Amortization	0.81	0.79	0.7	0.52	0.45	Upgrade
Stock-Based Compensation	5.29	3.84	2.8	1.69	1.25	Upgrade
Change in Accounts Payable	-0.39	-2.18	4.6	1.2	-0.26	Upgrade
Change in Unearned Revenue	-	-	34	1	-	Upgrade
Change in Other Net Operating Assets	-0.55	-0.97	-0.43	-0.5	-0.85	Upgrade
Operating Cash Flow	-33.07	-47.34	8.64	-20.87	-21.62	Upgrade
Capital Expenditures	-0.01	-0.15	-0.37	-0.13	-0.25	Upgrade
Investing Cash Flow	-0.01	-0.15	-0.37	-0.13	-0.25	Upgrade
Short-Term Debt Repaid	-	-	-	-	-0.38	Upgrade
Long-Term Debt Repaid	-0.01	-0	-0.05	-0.09	-0.08	Upgrade
Total Debt Repaid	-0.01	-0	-0.05	-0.09	-0.46	Upgrade
Net Debt Issued (Repaid)	-0.01	-0	-0.05	-0.09	-0.46	Upgrade
Issuance of Common Stock	29.33	14.87	23.16	35.31	76.64	Upgrade
Financing Cash Flow	29.32	14.87	23.11	35.22	76.18	Upgrade
Net Cash Flow	-3.76	-32.62	31.39	14.22	54.31	Upgrade
Free Cash Flow	-33.08	-47.49	8.28	-21	-21.87	Upgrade
Free Cash Flow Margin	-	-58627.16%	803.69%	-1835.58%	-	Upgrade
Free Cash Flow Per Share	-1.10	-1.78	0.34	-1.02	-1.80	Upgrade
Cash Interest Paid	-	-	-	-	0.01	Upgrade
Levered Free Cash Flow	-20.63	-29.7	-14.7	-11.88	-13.34	Upgrade
Unlevered Free Cash Flow	-20.63	-29.7	-14.7	-11.88	-13.34	Upgrade
Change in Net Working Capital	0.4	1.73	-3.49	-1.64	0.79	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q